Exelon Corporation (EXC) Stock Analysis

31.0/100
Sell Not Halal Utilities
Price $46.25
Market Cap $47.86B
52-Week Change +1.76%

Is EXC a good investment?

Exelon Corporation (EXC) has a Plutrex AI rating of 31.0/100 as of November 13, 2026, indicating a Sell consensus. The stock is not classified as halal-compliant. Key strength: Revenue growth 9.2% exceeds industry average 8.15% by 12.9%, driven by rate base expansion and successful rate case execution — the one operational metric where EXC leads peers, suggesting regulatory relationships remain constructive. Main concern: PEG ratio WORSENED to 3.24x (from 3.05x prior, now 20.9% above industry average of 2.68x) while P/E expanded to 17.82x (from 16.82x) — the stock is becoming MORE expensive with zero fundamental improvement; at fair-value PEG of 2.0x on 5.5% growth, implied intrinsic value is ~$28-$33 (before any regulatory premium), representing 24-38% downside from $45.63.

Investment Summary

EXC remains a structurally challenged regulated utility that has become MORE expensive since our prior Sell recommendation 14 days ago. The stock is essentially flat (-0.6% to $45.63) but fundamental deterioration has continued: P/E expanded from 16.82x to 17.82x (+5.9%), PEG worsened from 3.05x to 3.24x (+6.1%), and the analyst consensus target was trimmed from $47.75 to $47.67, leaving only 4.5% upside. At PEG 3.24x on 5.5% five-year EPS growth — 20.9% above the industry average PEG of 2.68x — investors are paying a material growth premium for a company that is a 30% growth laggard versus peers. FCF is deeply negative at -$2.585B annually, D/E is 1.70x (10.4% above the industry average of 1.54x), ROE is 9.06% (23.3% below the industry average of 11.82%), and historical earnings growth was -18.6% versus peers averaging +29.3% — a catastrophic 48-percentage-point gap. News sentiment is genuinely positive at 89/100 (Zacks Buy upgrade, record power demand projections, below-average customer rates), but no headline resolves the structural FCF deficit or valuation excess. The investment case remains a Sell at current prices; fair value using a utility-appropriate PEG of 2.0x on 5.5% growth implies a P/E of ~11x, yielding intrinsic value of approximately $28-$33, with a 10-15% regulatory defensiveness premium pushing a realistic entry zone to $35-$38.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
20/100
Growth Potential
15/100
Valuation
18/100
Profitability
38/100
Debt Management
20/100
Analyst Sentiment
52/100
Technical Momentum
42/100
Insider Confidence
45/100
News Sentiment
75/100

Fundamental Analysis

Profitability: Gross margin 26.7% (vs industry 29.74%, -10.2% gap), operating margin 19.8% (vs industry 23.12%, -14.4% gap), net margin 10.17% (vs industry 14.78%, -31.2% gap — the largest relative shortfall). The 16.5pp spread between gross and net margin reflects an excessive debt service burden. ROE 9.06% vs industry 11.82% (-23.3%). Growth: Revenue growth 9.2% (vs industry 8.15% — the one outperformance), but this top-line strength is not flowing through: EPS YoY growth -0.4%, historical earnings growth -18.6% vs industry +29.3%. Forward 5-year EPS growth 5.5% vs industry 7.89% (-30.3% deficit). Financial Health: D/E 1.70x vs industry 1.54x (+10.4%), FCF -$2.585B annually with only $1.47B cash cushion (~7 months of burn), creating structural dependency on capital markets. Valuation: P/E 17.82x vs industry 16.73x (+6.5% premium), PEG 3.24x vs industry 2.68x (+20.9% premium). With analyst consensus target $47.67 vs current $45.63, only 4.5% upside is available — inadequate compensation for a leveraged, negative-FCF utility growing earnings at 5.5% annually. P/B 1.57x provides modest floor support. Fair value at 11-13x P/E = $28-$33, with a 15% regulatory premium = $32-$38 fair value range.

News Sentiment

Exelon Is Getting Some Love From Wall Street — But Should Investors Buy In? Electricity giant Exelon is riding a wave of good news, but analysts warn the stock's fundamentals may not justify the enthusiasm. The Chicago-based utility, which powers millions of homes across the Mid-Atlantic and Midwest, recently received a vote of confidence from Zacks Investment Research, which upgraded the stock to a Buy rating — citing what it calls improving earnings momentum. The timing couldn't be better for Exelon's narrative. The U.S. Energy Information Administration just projected that American electricity consumption will hit record highs in both 2026 and 2027, fueled largely by the explosive growth of AI data centers. That's potentially great news for a company that owns and operates massive transmission and distribution networks. 'The Hidden Catalyst That Could Send Exelon Stock Back to $50' was the headline making rounds ahead of the company's Q3 earnings call — a teaser that captured investor imagination. On the customer-facing side, Exelon also scored points by maintaining rates below the national average during this summer's brutal heat waves, while simultaneously filing a FERC complaint to protect customers from what it called 'unreasonable costs' — a regulatory move that positions the company as a consumer advocate. But here's the catch: none of this good news has yet translated into stronger earnings growth. Exelon's forward EPS growth rate sits at just 5.5% annually — roughly 30% below what the average regulated utility peer is expected to deliver. The stock trades at a PEG ratio of 3.24x, meaning investors are paying a significant premium for relatively modest growth. The question for everyday investors: is the AI electricity boom enough to change Exelon's fundamental story?

Risk Assessment

PRIMARY RISK (downside): Valuation compression to fair value represents 24-38% downside. At PEG 2.0x (fair for a levered, negative-FCF utility growing at 5.5%) × 5.5% growth = 11.0x fair P/E. At EPS ~$2.56, intrinsic value = ~$28.16; adding a 15-20% regulatory defensiveness premium yields $32-$34. Even at the generous 13-14x P/E peer-discount multiple, fair value is $33-$36. SECONDARY RISK: FCF deterioration (-$2.585B, worsened from -$1.916B) could force dividend cut or equity issuance, triggering a sharp re-rating. Rising interest rates amplify the D/E 1.70x leverage burden. UPSIDE RISKS (why we're not more aggressive on the sell): (1) Record power demand catalysts from AI buildout could accelerate rate base expansion beyond the 5.5% EPS growth trajectory; (2) Regulatory wins (rate cases, FERC complaints) could reduce cost pressure; (3) Zacks Buy upgrade and 89/100 news sentiment suggest positive near-term momentum that could keep the stock elevated longer than fundamentals justify. MITIGATION: 1% position sizing limits exposure for utility-mandated accounts; full exit recommended for discretionary accounts above $38.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is EXC a halal stock?

No, Exelon Corporation (EXC) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for EXC?

Exelon Corporation (EXC) has a Plutrex AI rating of 31.0/100 with a Sell consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is EXC a good investment?

According to Plutrex AI, EXC has a Sell rating (31.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in EXC?

US stocks like EXC can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in EXC?

Plutrex AI identifies the main risks for EXC by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with ElBarake AI about EXC

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open EXC in ElBarake